Par Drugs and Chemicals Limited (PAR.NS)
INR 103.99
(4.61%)
INR 103.99
(4.61%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 11.78 INR | 27.9% |
| 2022 | 9.21 INR | 22.96% |
| 2021 | 7.49 INR | -60.31% |
| 2020 | 18.87 INR | 143.48% |
| 2019 | 7.75 INR | 293.4% |
| 2018 | 1.97 INR | 61.48% |
| 2017 | 1.22 INR | -18.67% |
| 2016 | 1.50 INR | 92.31% |
| 2015 | 0.78 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 2.06 INR | -31.79% |
| 2024 Q2 | 6.99 INR | 239.32% |
| 2023 Q2 | 3.98 INR | 98.01% |
| 2023 Q1 | 2.01 INR | -28.21% |
| 2023 Q3 | 2.78 INR | -30.15% |
| 2023 Q4 | 3.02 INR | 8.63% |
| 2023 FY | - INR | 27.9% |
| 2022 Q2 | 3.03 INR | 62.9% |
| 2022 Q4 | 2.80 INR | 84.21% |
| 2022 FY | - INR | 22.96% |
| 2022 Q1 | 1.86 INR | -5.58% |
| 2022 Q3 | 1.52 INR | -49.83% |
| 2021 Q1 | 2.00 INR | -44.29% |
| 2021 FY | - INR | -60.31% |
| 2021 Q4 | 1.97 INR | 14.53% |
| 2021 Q3 | 1.72 INR | -4.44% |
| 2021 Q2 | 1.80 INR | -10.0% |
| 2020 Q4 | 3.59 INR | 5.9% |
| 2020 Q3 | 3.39 INR | 62.98% |
| 2020 FY | - INR | 143.48% |
| 2020 Q1 | 2.08 INR | 61.24% |
| 2020 Q2 | 2.08 INR | 0.0% |
| 2019 Q4 | 1.29 INR | 0.0% |
| 2019 FY | - INR | 293.4% |
| 2019 Q3 | 1.29 INR | 98.46% |
| 2019 Q2 | 0.65 INR | 0.0% |
| 2019 Q1 | 0.65 INR | 282.35% |
| 2018 Q4 | 0.17 INR | 0.0% |
| 2018 FY | - INR | 61.48% |
| 2018 Q1 | 1.27 INR | 0.0% |
| 2018 Q2 | 1.27 INR | 0.0% |
| 2018 Q3 | 0.17 INR | -86.61% |
| 2017 FY | - INR | -18.67% |
| 2016 FY | - INR | 92.31% |
| 2015 FY | - INR | 0.0% |